Go Deep
Niki BioSolutions, Inc.
Niki BioSolutions, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,822 | -0.8 | 0.30 | 0.28 | 210.27 |
| Oct 2026 | 24,890 | -0.7 | 0.27 | 0.28 | 192.27 |
| Oct 2026 | 24,872 | -0.7 | 0.28 | 0.28 | 197.22 |
| Oct 2026 | 24,890 | -0.7 | 0.27 | 0.28 | 192.48 |
| Oct 2026 | 24,901 | -0.7 | 0.27 | 0.28 | 189.16 |
| Oct 2026 | 24,951 | -0.6 | 0.25 | 0.28 | 175.57 |
| Oct 2026 | 24,962 | -0.6 | 0.25 | 0.28 | 173.45 |
Niki BioSolutions, Inc. Quarterly Results
| Line Item | Dec 2025 | Sep 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -307,495.0 | -613,995.0 |
Niki BioSolutions, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 431,378.0 | 1,295,889.0 | — |
| Net Profit | -1,363,270.0 | -4,267,806.0 | -2,824,647.0 | -9,799,560.0 | — |
| EPS | — | -7.8 | -6.2 | -27.5 | -71.5 |
Niki BioSolutions, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 18,691,370.0 | 16,130,223.0 | 20,640,091.0 | 20,867,371.0 | — |
| Total Liabilities | 4,899,823.0 | 4,353,162.0 | 5,256,738.0 | 13,034,066.0 | — |
| Total Equity | 23,162,160.0 | 21,134,514.0 | 24,846,236.0 | 15,712,094.0 | — |
Owes vs Owns
Niki BioSolutions, Inc. owed $0.26 for every $1 it owned in Dec 2025, down from $0.62 in Dec 2022.
| Period | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Owes vs Owns | 0.26× | 0.27× | 0.25× | 0.62× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Niki BioSolutions, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 18.5%Long-term investments 80.8%Other assets 0.7%
How it's funded — Dec 2025
Short-term debt 18.3%Payables 5.9%Other liabilities 2.1%Shareholders' equity 73.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3.5 | 0.9 | 2.0 | 2.0 |
| Receivables | 0.0 | 0.0 | 0.1 | 1.4 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 1.8 | 3.2 |
| Intangible assets | 0.0 | 0.0 | 0.1 | 0.8 |
| Long-term investments | 15.1 | 15.1 | 16.1 | 9.7 |
| Other assets | 0.1 | 0.2 | 0.5 | 3.8 |
| Liabilities & equity | ||||
| Short-term debt | 3.4 | 3.2 | 0.1 | 6.0 |
| Long-term debt | 0.0 | 0.0 | 3.1 | 0.5 |
| Payables | 1.1 | 1.0 | 2.0 | 6.1 |
| Other liabilities | 0.4 | 0.1 | 0.1 | 0.5 |
| Shareholders' equity | 13.8 | 11.8 | 15.4 | 7.8 |
| Net tangible assets | 23.2 | 21.1 | 24.7 | 15.0 |
Niki BioSolutions, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -1,836,546.0 | -1,189,734.0 | -7,724,364.0 | -12,318,965.0 | — |
| Investing Activities | 0.0 | 58,621.0 | 624,767.0 | 2,444,896.0 | — |
| Financing Activities | 4,415,199.0 | 0.0 | 4,092,068.0 | 6,625,462.0 | — |